Silo Pharma, Inc.(SILO)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Silo Pharma, Inc. (SILO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SILO at 13.4/100 on a 32-signal composite quality model, placing it at rank #2,875 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of SILO by reported 13-F value include AdvisorShares Investments, FNY Investment Advisers, CITADEL ADVISORS, based on the most recent SEC filings. SILO trades on the Nasdaq exchange and files with the SEC under CIK 1514183. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SILO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Silo Pharma, Inc. directly from SEC EDGAR.
AI Quality Score
13.4/100
AI Rank
#2,875
Revenue
$0.00
Net Income
$-832.8K
SILO key financials by period
Silo Pharma, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$72.1K
$-4.2M
—
FY 2024
10-K
$72.1K
$-4.4M
—
FY 2023
10-K
$72.1K
$-3.7M
—
FY 2022
10-K
$72.1K
$-3.9M
—
FY 2020
10-K/A
$40.9K
$-3.0M
—
FY 2019
10-K/A
$40.6K
$-1.0M
—
Institutions holding SILO
Institutional investors reporting a position in Silo Pharma, Inc. on SEC Form 13F.
